These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ellenberg SS; Temple R Ann Intern Med; 2000 Sep; 133(6):464-70. PubMed ID: 10975965 [TBL] [Abstract][Full Text] [Related]
3. Innovation and placebos in research: a new design of clinical trial. Holbrook A; Goldsmith C Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799 [No Abstract] [Full Text] [Related]
5. What is controlled for in placebo-controlled trials? Fillingim RB; Price DD Mayo Clin Proc; 2005 Sep; 80(9):1119-21. PubMed ID: 16178490 [No Abstract] [Full Text] [Related]
6. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Temple R; Ellenberg SS Ann Intern Med; 2000 Sep; 133(6):455-63. PubMed ID: 10975964 [TBL] [Abstract][Full Text] [Related]
8. Sham-Controlled Trials for Coronary Interventions: Ethically Acceptable and Ethically Important. Dickert NW; Miller FG J Am Coll Cardiol; 2018 Jan; 71(1):95-97. PubMed ID: 29301633 [No Abstract] [Full Text] [Related]
9. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists? Simon R Ann Intern Med; 2000 Sep; 133(6):474-5. PubMed ID: 10975967 [No Abstract] [Full Text] [Related]
10. Patients' willingness to participate in placebo-controlled trials of antihypertensive therapy. Al-Khatib SM; Biswas MS Am Heart J; 2003 Dec; 146(6):944-5. PubMed ID: 14660983 [No Abstract] [Full Text] [Related]
11. Placebo: its action and place in health research today--summary and conclusions. Spier RE Sci Eng Ethics; 2004 Jan; 10(1):189-97. PubMed ID: 14986785 [TBL] [Abstract][Full Text] [Related]
12. Placebos and the UK Medical Research Council--and the consumer perspective. Box JE Sci Eng Ethics; 2004 Jan; 10(1):95-101. PubMed ID: 14986776 [TBL] [Abstract][Full Text] [Related]
13. Are placebo-controlled trials still important for obsessive compulsive disorder? Fineberg NA; Hawley CJ; Gale TM Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):413-22. PubMed ID: 16413647 [TBL] [Abstract][Full Text] [Related]
14. Do we need placebos to evaluate new drugs in children with schizophrenia? Armenteros JL; Mikhail AG Psychopharmacology (Berl); 2002 Jan; 159(2):117-24. PubMed ID: 11862338 [TBL] [Abstract][Full Text] [Related]
15. Ethical issues in the difference between placebo-controlled and active-controlled trials. Petrini C Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197 [No Abstract] [Full Text] [Related]
16. The powerful placebo: doubting the doubters. Greene PJ; Wayne PM; Kerr CE; Weiger WA; Jacobson E; Goldman P; Kaptchuk TJ Adv Mind Body Med; 2001; 17(4):298-307; discussion 312-8. PubMed ID: 11931055 [No Abstract] [Full Text] [Related]
17. The ethics of placebo-controlled trials--a middle ground. Emanuel EJ; Miller FG N Engl J Med; 2001 Sep; 345(12):915-9. PubMed ID: 11565527 [No Abstract] [Full Text] [Related]
18. Does the placebo exist? Adv Mind Body Med; 2001; 17(4):291-2. PubMed ID: 11931052 [No Abstract] [Full Text] [Related]
19. Research, medicine, and "placebos". Moerman DE Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201 [No Abstract] [Full Text] [Related]